Director at Rocket Pharmaceuticals (RCKT) receives RSUs and stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ROCKET PHARMACEUTICALS, INC. director Fady Ibraham Malik reported receiving equity awards tied to the company’s common stock. He was granted 22,862 restricted stock units that convert into common shares on a one-for-one basis and will vest in full on June 18, 2027.
He also received a stock option covering 64,860 shares of common stock at an exercise price of $3.35 per share, which will become fully vested and exercisable on June 18, 2027 and expires on June 18, 2036. Following the RSU grant, he directly holds 52,862 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Malik Fady Ibraham
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 64,860 | $0.00 | -- |
| Grant/Award | Common Stock | 22,862 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 64,860 shares (Direct, null);
Common Stock — 52,862 shares (Direct, null)
Footnotes (1)
- Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027. This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Key Figures
RSU grant: 22,862 RSUs
Stock option grant: 64,860 options
Option exercise price: $3.35 per share
+2 more
5 metrics
RSU grant
22,862 RSUs
Restricted stock units vesting June 18, 2027
Stock option grant
64,860 options
Right to buy common stock, vesting June 18, 2027
Option exercise price
$3.35 per share
Exercise price for 64,860-share stock option
Shares held after grant
52,862 shares
Common stock directly owned following RSU award
Option expiration
June 18, 2036
Expiration date of the 64,860-share option
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), vest, exercise price
4 terms
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock"
vest financial
"The RSUs will vest in full on June 18, 2027."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"This option represents a right to purchase a total of 64,860 shares"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What did Rocket Pharmaceuticals (RCKT) director Fady Malik report in this Form 4?
Fady Malik reported receiving equity awards in Rocket Pharmaceuticals. He was granted 22,862 restricted stock units plus a stock option for 64,860 shares, both linked to common stock and vesting on June 18, 2027.
How many Rocket Pharmaceuticals (RCKT) RSUs were granted to Fady Malik?
Fady Malik received 22,862 restricted stock units. These RSUs convert into Rocket Pharmaceuticals common stock on a one-for-one basis and will vest in full on June 18, 2027 if the standard vesting conditions are satisfied.
What are the terms of Fady Malik’s new stock option in Rocket Pharmaceuticals (RCKT)?
He received a stock option for 64,860 shares of common stock at a $3.35 exercise price. The option becomes fully vested and exercisable on June 18, 2027 and expires on June 18, 2036, according to the filing footnote.
When do Fady Malik’s Rocket Pharmaceuticals (RCKT) RSUs and options vest?
Both the RSUs and the stock option vest on June 18, 2027. The RSUs then convert one-for-one into common shares, while the option becomes fully exercisable for 64,860 shares at the stated exercise price.